Inzirqo Powder, For Suspension
NDC Package 70954-522-10

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Inzirqo (hydrochlorothiazide) powders is a medication used to treat high blood pressure. This formulation utilizes a powder, for suspension delivery system. Marketed by Ani Pharmaceuticals, Inc., this product is identified by NDC 70954-522 and is authorized under FDA application NDA219141.

Identification & Billing

NDC Package Code
70954-522-10
Package Description
80 mL in 1 BOTTLE
Product Code
70954-522
11-Digit Billing Format
70954052210
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
Units Per Package
80 ML
RxNorm Crosswalk
  • RxCUI: 2704012 - hydroCHLOROthiazide 800 MG (10 MG/mL) Powder for Oral Suspension
  • RxCUI: 2704012 - hydrochlorothiazide 800 MG Powder for Oral Suspension
  • RxCUI: 2704012 - HCTZ 800 MG Powder for Oral Suspension
  • RxCUI: 2704018 - INZIRQO 800 MG (10 MG/mL) Powder for Oral Suspension
  • RxCUI: 2704018 - hydrochlorothiazide 800 MG Powder for Oral Suspension [Inzirqo]

Clinical Specifications

Proprietary Name
Inzirqo
Non-Proprietary Name
Hydrochlorothiazide
Substance Name
Hydrochlorothiazide
Dosage Form
Powder, For Suspension - An intimate mixture of dry, finely divided drugs and/or chemicals, which, upon the addition of suitable vehicles, yields a suspension (a liquid preparation containing the solid particles dispersed in the liquid vehicle).
Administration Route
Oral - Administration to or by way of the mouth.
Active Ingredient(s)
HYDROCHLOROTHIAZIDE 10 mg/mL
Pharmacologic Class
Usage Information
This medication is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Hydrochlorothiazide belongs to a class of drugs known as diuretics/"water pills." It works by causing you to make more urine. This helps your body get rid of extra salt and water. This medication also reduces extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, or kidney disease. This can lessen symptoms such as shortness of breath or swelling in your ankles or feet.

Regulatory & Marketing

Labeler Name
Ani Pharmaceuticals, Inc.
Product Type
Human Prescription Drug
FDA Application #
NDA219141
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
01-30-2025
Listing Expiration
12-31-2026
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 70954-522-10 identifies a specific commercial package of 80 ml in 1 bottle of Inzirqo, a human prescription drug labeled by Ani Pharmaceuticals, Inc.. This powder, for suspension is formulated for oral use and contains hydrochlorothiazide as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Ani Pharmaceuticals, Inc. on January 30, 2025. The current certification is valid through December 31, 2026.

What are the primary indications for this medication?

This medication is used to treat high blood pressure. Lowering high blood pressure helps prevent strokes, heart attacks, and kidney problems. Hydrochlorothiazide belongs to a class of drugs known as diuretics/"water pills." It works by causing you to make more urine. This helps your body get rid of extra salt and water. This medication also reduces extra fluid in the body (edema) caused by conditions such as heart failure, liver disease, or kidney disease. This can lessen symptoms such as shortness of breath or swelling in your ankles or feet.

How is this Ani Pharmaceuticals, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 70954052210. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. There are 80 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
70954-522-10
11-Digit CMS (5-4-2)
70954-0522-10

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.